← Back to browse
HR 7970 Cleared committee

Adds a broad class of synthetic opioids called nitazenes to Schedule I of the Controlled Substances Act, making their scheduling permanent, and requires the Attorney General to issue implementing rules within one year.

Official title: STOP Nitazenes Act

Next stop House floor: awaiting a vote
Timeline each lane is a chamber; dates pull from congress.gov actions
House
Introduced 18-MAR-2026
Referred 18-MAR-2026
Approved by committee 21-JUL-2026
Key points
  • Adds 2-benzylbenzimidazole opioids, known as nitazenes, to Schedule I, covering any material containing them or their salts and isomers.
  • Defines the class by chemical structure and mu-opioid receptor agonist activity, and names eleven specific substances, including etonitazene and isotonitazene.
  • Allows the Attorney General to publish by order in the Federal Register a list of substances that meet the definition.
  • Makes substances previously under temporary scheduling permanent Schedule I substances as of the date of enactment.
  • Requires an interim final rule within one year, followed by a final rule after a comment period and hearing opportunity.
AI-generated from the Introduced in House text of 18-MAR-2026 · verify · report an error
Official CRS summary

No CRS summary yet. CRS writes one for most bills, often months after they move.

CRS is the Library of Congress's nonpartisan research office. Check on congress.gov
Committee referrals (3) Policy area

Crime and Law Enforcement

Sponsor Robert E. Latta (R-OH) Cosponsors · 10
■ 9 R■ 1 D